Filing Details
- Accession Number:
- 0001437749-24-036546
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-03 16:16:07
- Reporting Period:
- 2024-11-29
- Accepted Time:
- 2024-12-03 16:16:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1069530 | Cassava Sciences Inc | SAVA | Pharmaceutical Preparations (2834) | 911911336 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532303 | Eric Schoen | 6801 N Capital Of Texas Hwy, Bldg 1 Suite 300 Austin TX 78731 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-29 | 50,000 | $1.18 | 71,300 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-29 | 2,000 | $3.82 | 0 | No | 4 | S | Indirect | By limited liability corporation |
| Common Stock | Disposition | 2024-11-29 | 59,800 | $3.86 | 11,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Indirect | By limited liability corporation |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-11-29 | 50,000 | $0.00 | 50,000 | $1.18 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-11-30 | 2028-10-31 | No | 4 | M | Direct |
Footnotes
- 1. The sale reported in column 4 is a weighted average price. The shares were sold in multiple open market transactions at prices ranging from $3.81 to $3.89 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Billionaire Hedge Funds
